Predictive Role of sTREM in Endovascular Thrombectomy Outcomes
ConditionAcute Ischemic Stroke
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorThe Affiliated Hospital of Xuzhou Medical University
About this trial
Soluble triggering receptor expressed on myeloid cells (sTREM), which reflects microglia activation, has been reported closely associated with neuronal injury and neuroinflammation. This study is to investigatethe prognostic roles of sTREM (sTREM1 and sTREM2) in patients with ischemic stroke who underwent endovascular thrombectomy (EVT).
Eligibility criteria
Qualifiers
Patients > 18 years old.
Patients with acute large vessel occlusion within 24 hours of onset who will receive endovascular treatment.
Disqualifiers
Impossibility of getting a blood sample.
Impossibility of performing the test (Invalid results).
Refusal to provide the informed consent by the patient/relative.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
300 Participants
are grouped into 3 trial groupsSponsors and collaborators
Source ClinicalTrials.gov